Company intelligence / Profile preview

Zhonghe Capital

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Zhonghe Capital is a prominent Chinese private equity and venture capital firm that specializes in the healthcare, advanced manufacturing, and TMT (Technology, Media, and Telecommunications) sectors. Serving as the investment arm of the China United SME Guarantee Corporation (IIGF), the firm manages multiple funds focused on growth-stage and late-stage enterprises. In the healthcare sector, Zhonghe Capital is a significant investor in innovative biotechnology, medical devices, and pharmaceutical services, with a portfolio that includes market leaders such as MGI Tech and InnoCare Pharma. The firm provides strategic capital and industrial resources to support technological innovation and industrial upgrading within the Chinese life sciences ecosystem.

Industry: Investors

Beyond the preview

Go deeper on Zhonghe Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhonghe Capital.

Explore the full profile